Avalon Pharmaceuticals Inc

CIK 1162192 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Avalon Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Feb 16, 2010SC 13G/A0000950123-10-013105
Jan 26, 2010SC 13G/A0000947871-10-000063
Jun 30, 2009S-8 POS0000950123-09-019070
Jun 30, 2009EFFECT9999999995-09-001806
Jun 30, 2009POS AM0000950123-09-019131
Jun 30, 2009POS AM0000950123-09-019129
Jun 30, 2009S-8 POS0000950123-09-019124
Jun 30, 2009EFFECT9999999995-09-001805
Jun 30, 2009POS AM0000950123-09-019133
Jun 30, 200915-12B0000950123-09-019067
Jun 30, 2009EFFECT9999999995-09-001808
Jun 30, 2009EFFECT9999999995-09-001809
Jun 30, 2009POS AM0000950123-09-019128
Jun 30, 2009S-8 POS0000950123-09-019126
Jun 2, 20098-K0000950123-09-010495
Jun 1, 200940001209191-09-029771
Jun 1, 200940001209191-09-029772
Jun 1, 200940001209191-09-029769
May 28, 200925-NSE0001354457-09-000141
May 13, 200910-Q0000950133-09-001639
May 6, 20094250000950133-09-001464
May 6, 20098-K0000950133-09-001463
Apr 28, 20094250000950133-09-001274
Apr 2, 20098-K0000950133-09-000988
Apr 2, 20094250000950133-09-000989